Inspire Medical Systems, Inc. (INSP)
68.79
-1.33
(-1.90%)
USD |
NYSE |
Oct 16, 16:00
68.64
-0.15
(-0.22%)
Pre-Market: 20:00
Inspire Medical Systems Research and Development Expense (Annual) : 103.16M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 103.16M |
| December 31, 2024 | 114.13M |
| December 31, 2023 | 116.54M |
| December 31, 2022 | 68.64M |
| December 31, 2021 | 37.35M |
| December 31, 2020 | 26.09M |
| Date | Value |
|---|---|
| December 31, 2019 | 12.84M |
| December 31, 2018 | 7.388M |
| December 31, 2017 | 6.194M |
| December 31, 2016 | 7.091M |
| December 31, 2015 | 7.079M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Intuitive Surgical, Inc. | 1.312B |
| Stryker Corp. | 1.567B |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Inogen, Inc. | 19.18M |